CXCL13 and hypohidrotic ectodermal dysplasia: To assess whether the concentrations of CXCL13 and sCD27 at baseline were determinants for EDA during the follow-up period after AHSCT, patients with at least 4 years of follow-up (n = 26) were analyzed further.